Clinical Trial Update: Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi [Phase 2]

View source ↗

Summary

This clinical trial update reports safety and efficacy results from a Phase 2 study of rituximab for multicentric Castleman disease in Malawi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multicentric Castleman Disease

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Multicentric Castleman Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-09-11